Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis

Innate Immunity

Volumn 21, Issue 4, 2015, Pages 370-385

  Turunen, S Pauliina ^a,b,d   Kummu, Outi ^a,b,d   Wang, Chunguang ^a,d   Harila, Kirsi ^a,d   Mattila, Riikka ^a,d   Sahlman, Marjo ^a,d   Pussinen, Pirkko J ^c   Hörkkö, Sohvi ^a,b,d  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

atherosclerosis; innate immunity; lipid peroxidation; malondialdehyde; Natural antibodies; periodontitis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 5; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MALONDIALDEHYDE MODIFIED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; CYTOKINE; EPITOPE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LIPID DIET; LIPID STORAGE; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; SPLEEN CELL; ANIMAL; AORTA; BACTEROIDACEAE INFECTION; BLOOD; C57BL MOUSE; CHEMISTRY; COMPLICATION; CROSS REACTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PERIODONTITIS;

BACTERIA (MICROORGANISMS); MUS; PORPHYROMONAS GINGIVALIS;

ANIMALS; AORTA; ATHEROSCLEROSIS; BACTEROIDACEAE INFECTIONS; CROSS REACTIONS; CYTOKINES; DIET, HIGH-FAT; EPITOPES, B-LYMPHOCYTE; FEMALE; IMMUNITY, INNATE; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RECEPTORS, LDL;

EID: 84926490181     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425914542444     Document Type: Article

References (59)

1. Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012 ; 125: 2520-2544
2. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol. 2013 ; 84: S51 - S69
3. Li L, Messas E, Batista EL Jr, et al. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002 ; 105: 861-867
4. Lalla E, Lamster IB, Hofmann MA, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2003 ; 23: 1405-1411
5. Gibson FC, 3rd, Hong C, Chou HH, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004 ; 109: 2801-2806
6. Maekawa T, Takahashi N, Tabeta K, et al. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One. 2011 ; 6: e20240 - e20240
7. Jain A, Batista EL Jr, Serhan C, et al. Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun. 2003 ; 71: 6012-6018
8. Brodala N, Merricks EP, Bellinger DA, et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1446-1451
9. Miyamoto T, Yumoto H, Takahashi Y, et al. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. Infect Immun. 2006 ; 74: 1376-1380
10. Hayashi C, Viereck J, Hua N, et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis. 2011 ; 215: 52-59
11. Turunen SP, Kummu O, Harila K, et al. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. PLoS One. 2012 ; 7: e34910 - e34910
12. Kang IC, Kuramitsu HK. Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol. 2002 ; 34: 311-317
13. Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog. 2003 ; 35: 259-267
14. Miller YI, Choi SH, Wiesner P, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011 ; 108: 235-248
15. Tsiantoulas D, Gruber S, Binder CJ. B-1 cell immunoglobulin directed against oxidation-specific epitopes. Front Immunol. 2012 ; 3: 415-415
16. Palinski W, Ord VA, Plump AS, et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994 ; 14: 605-616
17. Freigang S, Hörkkö S, Miller E, et al. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol. 1998 ; 18: 1972-1982
18. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A. 1995 ; 92: 821-825
19. Ameli S, Hultgardh-Nilsson A, Regnstrom J, et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1996 ; 16: 1074-1079
20. Nilsson J, Calara F, Regnstrom J, et al. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 1997 ; 30: 1886-1891
21. Karvonen J, Päivänsalo M, Kesäniemi YA, et al. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation. 2003 ; 108: 2107-2112
22. Tsimikas S, Brilakis ES, Lennon RJ, et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res. 2007 ; 48: 425-433
23. Tsimikas S, Willeit P, Willeit J, et al. Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. J Am Coll Cardiol. 2012 ; 60: 2218-2229
24. Binder CJ. Natural IgM Abs against oxidation-specific epitopes. J Clin Immunol. 2010 ; 30 (Suppl. 1). S56 - S60
25. Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation. 2009 ; 120: 417-426
26. Kyaw T, Tay C, Krishnamurthi S, et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res. 2011 ; 109: 830-840
27. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med. 2010 ; 207: 1579-1587
28. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 ; 34: 1345-1353
29. Habeeb AF. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 1966 ; 14: 328-336
30. Kuula H, Salo T, Pirilä E, et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun. 2009 ; 77: 850-859
31. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995 ; 36: 2320-2328
32. Movat HZ. Demonstration of all connective tissue elements in a single section; pentachrome stains. AMA Arch Pathol. 1955 ; 60: 289-295
33. Petrovic A, Abramovic M, Mihailovic D, et al. Multicolor counterstaining for immunohistochemistry - a modified Movat's pentachrome. Biotech Histochem. 2011 ; 86: 429-435
34. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
35. Kummu O, Turunen SP, Wang C, et al. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. Antioxid Redox Signal. 2013 ; 19: 1047-1062
36. Inagaki S, Ishihara K, Yasaki Y, et al. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis. J Periodontol. 2003 ; 74: 1432-1439
37. Binder CJ, Hartvigsen K, Chang MK, et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest. 2004 ; 114: 427-437
38. Pavlidis P, Noble WS. Matrix2png: a utility for visualizing matrix data. Bioinformatics. 2003 ; 19: 295-296
39. Shaw PX, Hörkkö S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000 ; 105: 1731-1740
40. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989 ; 298: 779-781
41. DeStefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993 ; 306: 688-691
42. Mattila KJ, Valtonen VV, Nieminen M, et al. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis. 1995 ; 20: 588-592
43. Hung HC, Joshipura KJ, Colditz G, et al. The association between tooth loss and coronary heart disease in men and women. J Public Health Dent. 2004 ; 64: 209-215
44. Humphrey LL, Fu R, Buckley DI, et al. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med. 2008 ; 23: 2079-2086
45. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011 ; 12: 204-212
46. Ludewig B, Krebs P, Scandella E. Immunopathogenesis of atherosclerosis. J Leukoc Biol. 2004 ; 76: 300-306
47. van Steenbergen TJ, Kastelein P, Touw JJ, et al. Virulence of black-pigmented Bacteroides strains from periodontal pockets and other sites in experimentally induced skin lesions in mice. J Periodontal Res. 1982 ; 17: 41-49
48. Neiders ME, Chen PB, Suido H, et al. Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res. 1989 ; 24: 192-198
49. Khallou-Laschet J, Tupin E, Caligiuri G, et al. Atheroprotective effect of adjuvants in apolipoprotein E knockout mice. Atherosclerosis. 2006 ; 184: 330-341
50. Takatsu K, Kouro T, Nagai Y. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol. 2009 ; 101: 191-236
51. Sämpi M, Ukkola O, Päivänsalo M, et al. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol. 2008 ; 52: 1370-1378
52. Bzowska M, Nogiec A, Skrzeczynska-Moncznik J, et al. Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis. Inflammation. 2012 ; 35: 1567-1584
53. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996 ; 97: 1715-1722
54. Aiello RJ, Bourassa PA, Lindsey S, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1999 ; 19: 1518-1525
55. McKellar GE, McCarey DW, Sattar N, et al. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol. 2009 ; 6: 410-417
56. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011 ; 13: 11-22
57. Wiesner P, Tafelmeier M, Chittka D, et al. MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma. J Lipid Res. 2013 ; 54: 1877-1883
58. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998 ; 2: 275-281
59. Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol. 1998 ; 152: 423-430